New Nitrogen-, Oxygen-, and Sulfur-Containing Heterocyclic Compounds as Anti-Colon Cancer Agents: Synthesis,

Nahed Nasser Eid El-Sayed1, Najeh Krayem2, Hamed Ahmed Derbala3

  • 1Egyptian Drug Authority, 51 Wezaret El-Zerra St., Giza 35521, Egypt.

Insights

Novel thiophene compounds show promise as multi-target agents against colorectal cancer by inhibiting key pathways like oxidative stress and the Warburg effect. Further optimization is needed to improve solubility and bioavailability for potential drug development.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Biochemistry

Background:

  • Colorectal cancer hallmarks include oxidative stress, the Warburg effect, and apoptosis resistance.
  • Developing multi-target compounds is crucial for effective cancer therapy.

Purpose of the Study:

  • To synthesize and evaluate novel compounds targeting key pathways in colorectal tumorigenesis.
  • To identify lead compounds with potent anticancer activity and favorable safety profiles.

Main Methods:

  • Synthesis of 24 novel compounds with diverse heterocyclic scaffolds.
  • Evaluation of antioxidant activity, PDK-1/LDHA inhibition, and cytotoxicity against colon cancer cells (LoVo, HCT-116) and normal cells (HUVECs).
  • In-depth mechanistic studies including cell cycle analysis, apoptosis induction, ROS levels, mitochondrial potential, gene expression, molecular docking, and in silico ADMET predictions.

Main Results:

  • Thiophenes 3b and 3d demonstrated potent inhibition of PDK-1/LDHA and antioxidant activity, with significant cytotoxicity against colon cancer cells (IC50 values in µM range) and minimal toxicity to normal cells.
  • Molecular docking confirmed favorable interactions with LDHA and PDK-1 active sites.
  • Compound 3d induced cell cycle arrest (G2/M or G1), promoted apoptosis via ROS generation, modulated Bax/Bcl-2 expression, disrupted mitochondrial potential, and activated caspase-3. In silico analysis suggested good drug-likeness but highlighted limitations in solubility and potential toxicity.

Conclusions:

  • Thiophenes 3b and 3d are promising multi-target candidates for anti-colon cancer therapy.
  • Structural optimization is necessary to enhance solubility, bioavailability, and safety for further preclinical development.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
4.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K